Lars Klareskog

Q: What Schools Are Affiliated With Lars Klareskog

Lars Klareskog is affiliated with the following schools: Uppsala University, Karolinska Institute

Lars Klareskog's AcademicInfluence.com Rankings

Lars Klareskog

Philosophy

#3436

World Rank

#5559

Historical Rank

Logic

#1160

World Rank

#1839

Historical Rank

philosophy Degrees

Lars Klareskog

Biology

#3688

World Rank

#5601

Historical Rank

Immunology

#163

World Rank

#171

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Lars Klareskog Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Lars Klareskog is a Swedish physician, immunologist, and rheumatologist, known for research into the genetics of autoimmune diseases such as rheumatoid arthritis . Klareskog received his medical degree from the University of Uppsala in 1974 and received his doctorate in 1978 with thesis On the structure, function and tissue distribution of HLA-DR and Ia antigens. From 1990 to 1993, he held the chair of clinical immunology at Uppsala University. He then held the chair of rheumatology at the Karolinska Institute and the Karolinska Clinic until 2012 and was head of the Rheumatology Clinic and Research Group. Since 2008 he is also director of the Center for Molecular Medicine.

(See a Problem?)

Lars Klareskog's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genetics of rheumatoid arthritis contributes to biology and drug discovery (2013) (1877)
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial (2004) (1841)
Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. (2008) (1547)
A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. (2006) (1501)
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci (2010) (1285)
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. (2007) (1041)
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) (2006) (840)
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in Rheumatoid Arthritis (2013) (831)
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. (2006) (820)
Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis (2011) (812)
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (2019) (724)
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. (2007) (711)
A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. (2004) (705)
Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases (2003) (665)
Incidence of cancer among patients with rheumatoid arthritis. (1993) (618)
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. (2005) (603)
High density genetic mapping identifies new susceptibility loci for rheumatoid arthritis (2012) (595)
Two independent alleles at 6q23 associated with risk of rheumatoid arthritis (2007) (592)
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. (2006) (563)
Common variants at CD40 and other loci confer risk of rheumatoid arthritis (2008) (550)
Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study (2008) (542)
Pervasive Sharing of Genetic Effects in Autoimmune Disease (2011) (537)
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. (2012) (522)
Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells (2008) (520)
Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. (1988) (514)
Immunity to citrullinated proteins in rheumatoid arthritis. (2008) (499)
Epidermal Langerhans cells express Ia antigens (1977) (479)
Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. (2007) (477)
Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis (2003) (473)
Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study (1998) (422)
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists (2005) (421)
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. (2005) (418)
The Swedish Twin Registry in the Third Millennium: An Update (2006) (413)
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists (2005) (411)
Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. (1986) (379)
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus (2010) (377)
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis (2010) (367)
Meta-Analysis of Genome-Wide Association Studies in Celiac Disease and Rheumatoid Arthritis Identifies Fourteen Non-HLA Shared Loci (2011) (355)
Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke (2010) (354)
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression (2005) (352)
CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease (2004) (350)
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis (2012) (349)
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction (2005) (346)
Genetic variants at CD28, PRDM1, and CD2/CD58 are associated with rheumatoid arthritis risk (2009) (343)
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists (2007) (339)
Specific interaction between genotype, smoking and autoimmunity to citrullinated α-enolase in the etiology of rheumatoid arthritis (2009) (326)
Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa (2019) (314)
Cytokine production, serum levels and disease activity in systemic lupus erythematosus. (2000) (308)
The Swedish Twin Registry: Establishment of a Biobank and Other Recent Developments (2012) (303)
The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting (2016) (295)
Citrullination is an inflammation-dependent process (2006) (293)
A Candidate Gene Approach Identifies the TRAF1/C5 Region as a Risk Factor for Rheumatoid Arthritis (2007) (293)
Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. (2004) (292)
A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis (2004) (291)
Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss (2015) (287)
A genome-wide association study of anorexia nervosa (2014) (284)
Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. (2003) (277)
Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. (1982) (270)
Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. (1997) (270)
Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. (2005) (269)
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register (2008) (268)
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis (2010) (267)
Analysis and Application of European Genetic Substructure Using 300 K SNP Information (2008) (261)
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment? (2009) (259)
Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity (2005) (258)
INDUCTION OF B-TYPE RECEPTORS FOR PLATELET-DERIVED GROWTH FACTOR IN VASCULAR INFLAMMATION: POSSIBLE IMPLICATIONS FOR DEVELOPMENT OF VASCULAR PROLIFERATIVE LESIONS (1988) (257)
Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases (2009) (256)
European Population Substructure: Clustering of Northern and Southern Populations (2006) (245)
Rheumatoid arthritis (2009) (242)
Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. (2005) (242)
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense (2003) (238)
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. (2007) (238)
Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts. (2011) (236)
T Lymphocytes in Collagen II‐Induced Arthritis in Mice (1985) (233)
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. (2010) (230)
Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case–control studies (2008) (229)
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. (2007) (228)
Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. (2008) (224)
Consensus statement on the use of rituximab in patients with rheumatoid arthritis (2006) (223)
Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. (2011) (223)
Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial. (2008) (218)
A role for noncoding variation in schizophrenia. (2014) (217)
Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. (2007) (217)
Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study (2004) (216)
Smoking as a trigger for inflammatory rheumatic diseases (2007) (214)
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005 (2004) (212)
Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition (2013) (207)
Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study (2005) (205)
Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis (2003) (204)
Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss (2015) (204)
Homologous type II collagen induces chronic and progressive arthritis in mice. (1986) (202)
Structural Changes and Antibody Enrichment in the Lungs Are Early Features of Anti–Citrullinated Protein Antibody–Positive Rheumatoid Arthritis (2014) (201)
Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles (2008) (200)
A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens. (2001) (199)
Genes, environment and immunity in the development of rheumatoid arthritis. (2006) (196)
Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. (1995) (194)
Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis (2017) (190)
Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. (2013) (190)
Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. (2003) (188)
Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. (2004) (185)
Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis. (2000) (185)
Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. (1989) (183)
Mechanisms of Disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis (2006) (182)
Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. (2006) (178)
Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. (2003) (177)
Occurrence of Ia antigens on tissues of non-lymphoid origin (1978) (174)
Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. (1988) (171)
Citrulline‐Specific Th1 Cells Are Increased in Rheumatoid Arthritis and Their Frequency Is Influenced by Disease Duration and Therapy (2014) (167)
Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. (2014) (167)
Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age. (2013) (166)
Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response (2007) (165)
Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. (2002) (165)
Relationships between HLA‐DR‐expressing Cells and T Lymphocytes of Different Subsets in Rheumatoid Synovial Tissue (1982) (164)
Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile (2012) (164)
Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis (2009) (159)
Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. (2009) (156)
Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases (2015) (156)
Swedish registers to examine drug safety and clinical issues in RA (2006) (156)
Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement (1991) (156)
Appearance of Anti‐HLA‐DR‐Reactive Cells in Normal and Rheumatoid Synovial Tissue (1981) (153)
Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism (2015) (153)
Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in fou (2010) (151)
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study (2010) (151)
Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant (1995) (150)
Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006 (2010) (149)
Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results (2005) (148)
Role of T lymphocytes in collagen II induced arthritis in rats. (1983) (148)
Hormonal regulation of the expression of la antigens on mammary gland epithelium (1980) (147)
Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome. (1985) (146)
Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency (2010) (146)
Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins (2013) (146)
Features of the Synovium of Individuals at Risk of Developing Rheumatoid Arthritis (2014) (145)
Presence of Human 65 kD Heat Shock Protein (hsp) in Inflamed Joints and Subcutaneous Nodules of RA Patients (1990) (145)
Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. (2009) (143)
Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. (2002) (140)
European biologicals registers: methodology, selected results and perspectives (2008) (139)
Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. (2001) (138)
The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. (2010) (138)
Platelet-derived growth factor receptors in the kidney--upregulated expression in inflammation. (1989) (137)
Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. (1990) (136)
Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis (2014) (136)
Adalimumab (Humira®) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade®) or etanercept (Enbrel®): results from the STURE registry at Karolinska University Hospital (2005) (135)
Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis (2014) (133)
Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II. (1985) (132)
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002) (2002) (132)
Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies (2014) (131)
Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium. (2004) (130)
Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. (1994) (130)
Dietary Fish and Fish Oil and the Risk of Rheumatoid Arthritis (2009) (128)
Integration of Sequence Data from a Consanguineous Family with Genetic Data from an Outbred Population Identifies PLB1 as a Candidate Rheumatoid Arthritis Risk Gene (2014) (128)
Quantifying Missing Heritability at Known GWAS Loci (2013) (127)
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials (2010) (125)
Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case–control study (2005) (123)
Gamma-interferon-like immunoreactivity in axotomized rat motor neurons (1989) (123)
Mechanisms involved in triggering rheumatoid arthritis (2016) (123)
Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis (2009) (123)
Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis. (1990) (121)
Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment (2000) (121)
Natural killer cells trigger differentiation of monocytes into dendritic cells. (2007) (118)
Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy. (2010) (117)
Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation (2014) (115)
Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis. (2006) (115)
GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma (2011) (114)
Rheumatoid arthritis and malignant lymphomas (2004) (113)
Phenotypic characterization in situ of inflammatory cells in allergic and irritant contact dermatitis in man. (1984) (112)
Association of arthritis with a gene complex encoding C-type lectin-like receptors. (2007) (110)
Phenotypic characterization of synovial tissue cells in situ in different types of synovitis. (1983) (110)
Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage (2015) (110)
Treatment with tumour necrosis factor α antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies (2004) (109)
Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect (2004) (108)
Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study. (2005) (107)
Role of hsp60 during Autoimmune and Bacterial Inflammation (1991) (106)
High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. (2015) (106)
Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia (2002) (105)
Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. (1987) (105)
TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex Traits (2015) (105)
Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone (2004) (104)
Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes from GWASs contribute to risk of rheumatoid arthritis. (2013) (104)
Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial (2007) (104)
GeMes, clusters of DNA methylation under genetic control, can inform genetic and epigenetic analysis of disease. (2014) (103)
Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFα receptors (2001) (103)
Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005. (2005) (102)
Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen. (1988) (100)
Animal models for arthritis: innovative tools for prevention and treatment (2011) (100)
Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case–control study (2012) (99)
A demineralization procedure for immunohistopathological use. EDTA treatment preserves lymphoid cell surface antigens. (1986) (99)
Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes (2018) (98)
Cytokine production in synovial tissue of mice with collagen‐induced arthritis (CIA) (1997) (98)
A protein involved in calcium sensing of the human parathyroid and placental cytotrophoblast cells belongs to the LDL-receptor protein superfamily. (1994) (98)
Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels. (2005) (98)
Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial (2005) (98)
Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk (2010) (97)
Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial (2005) (95)
Expression of Platelet‐Derived Growth Factor Receptors is Induced on Connective Tissue Cells During Chronic Synovial Inflammation (1988) (95)
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers (2016) (94)
Association between body mass index and anti–citrullinated protein antibody–positive and anti–citrullinated protein antibody–negative rheumatoid arthritis: Results from a population‐based case–control study (2013) (94)
Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. (2002) (94)
Immune functions of human synovial cells. Phenotypic and T cell regulatory properties of macrophage-like cells that express HLA-DR. (1982) (93)
A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity (2007) (93)
The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis (2010) (93)
Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus (2001) (92)
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003) (2003) (91)
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups (2009) (91)
Oestrogen induced suppression of collagen arthritis: I. Long term oestradiol treatment of DBA/1 mice reduces severity and incidence of arthritis and decreases the anti type II collagen immune response. (1987) (90)
Prevention of autoimmune rheumatic disease: state of the art and future perspectives (2010) (89)
Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis. (2009) (89)
Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers (2010) (88)
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept (2004) (87)
Recombinant Human Tissue Transglutaminase for Diagnosis and Follow-Up of Childhood Coeliac Disease (2002) (87)
Identification of rat susceptibility loci for adjuvant-oil-induced arthritis. (1997) (87)
Local enhancement of major histocompatibility complex (MHC) class I and II expression and cell infiltration in experimental allergic encephalomyelitis around axotomized motor neurons (1989) (86)
Ten years with biologics: to whom do data on effectiveness and safety apply? (2011) (86)
Expression of Ia antigen-like molecules on cells in the corneal epithelium. (1979) (86)
In Vivo Treatment of Rats with Monoclonal Anti‐T‐Cell Antibodies (1985) (86)
Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium (2002) (86)
A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs (2006) (86)
Occupational exposure to textile dust increases the risk of rheumatoid arthritis: results from a Malaysian population-based case–control study (2015) (84)
Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients (2006) (83)
Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. (2009) (83)
Occupation, occupational exposure to chemicals and rheumatological disease. A register based cohort study. (1994) (82)
Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell–Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis (2019) (81)
Antibodies to citrullinated proteins in arthritis: pathology and promise (2008) (81)
Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case–control study (2006) (80)
In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction. (1982) (80)
Interferon‐gamma‐like immunoreactivity in certain neurons of the central and peripheral nervous system (1989) (80)
Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides (2012) (79)
Characterization of T‐Cell Receptor αβ Repertoire in Synovial Tissue from Different Temporal Phases of Rheumatoid Arthritis (1992) (78)
Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis. (2011) (77)
Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families. (1999) (77)
A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides (2013) (77)
Autoantibodies to citrullinated proteins may induce joint pain independent of inflammation (2016) (77)
Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis. (2006) (77)
FOXP3 Identifies Regulatory CD25brightCD4+ T Cells in Rheumatic Joints (2006) (77)
Antibody reactivity against human and guinea pig tissue transglutaminase in children with celiac disease. (2000) (77)
Remaining Pain in Early Rheumatoid Arthritis Patients Treated With Methotrexate (2015) (76)
Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 ‘shared epitope’ alleles (2013) (75)
Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP. (2004) (74)
Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney. (1987) (74)
Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis (2016) (74)
Evolutionary relationship between immunoglobulins and transplantation antigens. (1975) (73)
No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts. (2009) (73)
The localization of hyaluronan in normal and rejected human kidneys. (1990) (73)
The Genetic Structure of the Swedish Population (2011) (73)
Expression of major histocompatibility antigens on pancreatic islet cells. (1981) (72)
Characterization of a spontaneously occurring arthritis in male DBA/1 mice. (1992) (72)
Smoking interacts with HLA-DRB1 shared epitope in the development of anti-citrullinated protein antibody-positive rheumatoid arthritis: results from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA) (2012) (72)
Down‐regulation of the T cell receptor CD3ζ chain in rheumatoid arthritis (RA) and its influence on T cell responsiveness (2000) (71)
Axotomy induces MHC class I antigen expression on rat nerve cells (1988) (70)
Prevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: A Swedish Population Based Case-Control Study (2016) (70)
Amelioration of collagen II‐induced arthritis in rats by the type IV phosphodiesterase inhibitor Rolipram (1997) (69)
In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats. (1985) (68)
High resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis. (2001) (68)
Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. (1990) (67)
A Role for VAV1 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis (2009) (66)
Reactivity of a Rabbit Antiserum against Highly Purified HLA‐DR Antigens (1978) (66)
Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis. (2013) (65)
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register (2010) (64)
MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen (2010) (64)
Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis* (2000) (64)
Chemical properties of human Ia antigens (1977) (63)
Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial (2012) (63)
Ambient Air Pollution Exposures and Risk of Rheumatoid Arthritis (2013) (63)
Susceptibility of DA Rats to Arthritis Induced With Adjuvant Oil or Rat Collagen is Determined by Genes Both Within and Outside the Major Histocompatibility Complex (1996) (63)
Identification of rat susceptibility loci for adjuvant-oil-induced arthritis (1998) (63)
Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway. (2005) (63)
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study (2021) (62)
Reactivity of monoclonal anti-type II collagen antibodies with cartilage and synovial tissue in rheumatoid arthritis and osteoarthritis. (1986) (62)
Interactions Between Amino Acid–Defined Major Histocompatibility Complex Class II Variants and Smoking in Seropositive Rheumatoid Arthritis (2015) (62)
What precedes development of rheumatoid arthritis? (2004) (62)
Isolation and properties of a murine spleen cell Fc receptor (1975) (62)
Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis (2016) (61)
Pathogenic Citrulline‐Multispecific B Cell Receptor Clades in Rheumatoid Arthritis (2018) (61)
Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies. (1988) (60)
TNF‐α Dominates Cytokine mRNA Expression in Lymphoid Tissues of Rats Developing Collagen‐ and Oil‐Induced Arthritis (1995) (60)
Smoking and susceptibility to rheumatoid arthritis in a Swedish population-based case–control study (2018) (60)
500-Kilodalton calcium sensor regulating cytoplasmic Ca2+ in cytotrophoblast cells of human placenta. (1990) (60)
A method to decipher pleiotropy by detecting underlying heterogeneity driven by hidden subgroups applied to autoimmune and neuropsychiatric diseases (2016) (59)
Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009 (2011) (59)
Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells. A role for macrophage-derived factors. (1992) (59)
Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus. (2000) (59)
Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis. (2006) (58)
Monoclonal anti-parathyroid antibodies interfering with a Ca2+-sensor of human parathyroid cells. (1987) (58)
Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study (2010) (58)
Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice. (2009) (58)
New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. (2015) (58)
Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology (2006) (57)
Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis (2018) (57)
Periodontal Health and Oral Microbiota in Patients with Rheumatoid Arthritis (2019) (56)
Cyclosporin A treatment in a case of relapsing polychondritis. (1984) (56)
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters intrathymic T-cell development in mice. (1990) (56)
Common variants at CD 40 and other loci confer risk of rheumatoid arthritis (2008) (56)
Clinical responses to tumor necrosis factor α antagonists do not show a bimodal distribution: Data from the Stockholm Tumor Necrosis Factor α Followup Registry (2003) (55)
Shared Epitope Alleles Remain A Risk Factor for Anti-Citrullinated Proteins Antibody (ACPA) – Positive Rheumatoid Arthritis in Three Asian Ethnic Groups (2011) (55)
Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis (2012) (54)
Adaptive immunity in rheumatoid arthritis: anticitrulline and other antibodies in the pathogenesis of rheumatoid arthritis (2014) (54)
Distribution of Ia‐Antigen‐like Molecules on Non‐lymphoid Tissues (1979) (54)
Rheumatoid arthritis and its animal models: the role of TNF-alpha and the possible absence of specific immune reactions. (1999) (53)
Effect of interactions of glutathione S-transferase T1, M1, and P1 and HMOX1 gene promoter polymorphisms with heavy smoking on the risk of rheumatoid arthritis. (2010) (53)
Origin of the autoreactive anti-type II collagen response. II. Specificities, antibody isotypes and usage of V gene families of anti-type II collagen B cells. (1989) (53)
HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus (2012) (53)
Multifunctional T cell reactivity with native and glycosylated type II collagen in rheumatoid arthritis. (2012) (52)
Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. (1997) (52)
Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint (2014) (51)
Structural Basis of Cross‐Reactivity of Anti–Citrullinated Protein Antibodies (2019) (51)
Association of Environmental and Genetic Factors and Gene–Environment Interactions With Risk of Developing Rheumatoid Arthritis (2013) (51)
Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious (2003) (50)
Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells. (1989) (50)
Appearance of Different Lymphoid Cells in Synovial Tissue and in Peripheral Blood during the Course of Collagen II‐Induced Arthritis in Rats (1985) (50)
Ia‐Expressing Cells and T Lymphocytes of Different Subsets in Peripheral Nerve Tissue during Experimental Allergic Neuritis in Lewis Rats (1983) (50)
H1N1 vaccination in Sjögren’s syndrome triggers polyclonal B cell activation and promotes autoantibody production (2017) (50)
Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis (2015) (48)
Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis (2012) (48)
Synovial biopsy in arthritis research: five years of concerted European collaboration (2000) (48)
Synovial Cells Responding to a 65‐kDa Mycobacterial Heat Shock Protein have a High Proportion of a TcRγδ Subtype Uncommon in Peripheral Blood (1990) (48)
Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. (1997) (48)
High antibody response to autologous type II collagen is restricted to H-2q (2004) (48)
A comparison between ELISPOT methods for the detection of cytokine producing cells: greater sensitivity and specificity using ELISA plates as compared to nitrocellulose membranes. (1997) (48)
Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis (2012) (48)
Enrichment of epidermal Langerhans cells: studies with a monolayer technique and flow cytometry sorting. (1982) (47)
Transforming Growth Factor‐β (TGF‐β) and Tissue Transglutaminase Expression in the Small Intestine in Children with Coeliac Disease (2002) (47)
Collagen induced arthritis: an experimental model for rheumatoid arthritis with involvement of both DTH and immune complex mediated mechanisms. (1989) (47)
Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis. (2012) (47)
Production of T-cell cytokines at the single-cell level in patients with inflammatory arthritides: enhanced activity in synovial fluid compared to blood. (1998) (46)
Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA. (2000) (46)
A simple immunoenzyme batch staining method for the enumeration of peripheral human T lymphocyte subsets. (1983) (46)
Generation of Monoclonal Rheumatoid Factors after Immunization with Collagen II‐Anti‐Collagen II Immune Complexes (1986) (46)
Preclinical target validation using patient-derived cells (2015) (46)
Autoimmunity in rheumatoid arthritis: citrulline immunity and beyond. (2013) (46)
The effect of female sex hormones on cancer survival. A register-based study in patients younger than 20 years at diagnosis. (1990) (46)
FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease (2020) (46)
Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats. (2002) (45)
Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate (2008) (45)
DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis (2017) (45)
Role of the Bowel Flora for Development of Immunity to hsp 65 and Arthritis in Three Experimental Models (1994) (45)
Associations With Smoking and Shared Epitope Differ Between IgA‐ and IgG‐Class Antibodies to Cyclic Citrullinated Peptides in Early Rheumatoid Arthritis (2015) (45)
Identification of H‐2 and Ia‐Antigen Analogues in Several Species by Immunological Crossreactions of Xenoantisera (1978) (45)
Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice (2011) (45)
An immunohistochemical analysis of cytokine expression in allergic and irritant contact dermatitis. (2000) (44)
Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history (2014) (44)
Genetic analysis of the contribution of IL10 to systemic lupus erythematosus. (1999) (43)
Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts (2019) (43)
Oil-induced arthritis in DA rats passive transfer by T cells but not with serum. (1993) (43)
Percutaneous exposure of adjuvant oil causes arthritis in DA rats (1994) (43)
Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies (2011) (43)
Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description (2004) (43)
Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis. (2017) (43)
Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families (2002) (42)
Dynamics of Ia-expressing cells and T lymphocytes of different subsets during experimental allergic neuritis in Lewis rats (1984) (41)
Immunohistochemical characterization of sialadenitis in NZB X NZW F1 mice. (1987) (41)
Patients with regular physical activity before onset of rheumatoid arthritis present with milder disease (2014) (41)
Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis (2019) (41)
Induction of class I and class II transplantation antigens in rat brain during fatal and non-fatal measles virus infection (1987) (40)
Higher education is associated with a better rheumatoid arthritis outcome concerning for pain and function but not disease activity: results from the EIRA cohort and Swedish rheumatology register (2015) (40)
Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study (2017) (40)
Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants (2017) (40)
Randomized withdrawal of long‐term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density (2007) (40)
Immunohistochemical characterization of synovial cells in arthritic MRL-lpr/lpr mice. (1987) (40)
Brief Report: Identification of BACH2 and RAD51B as Rheumatoid Arthritis Susceptibility Loci in a Meta-Analysis of Genome-Wide Data (2013) (40)
The role of adherent HLA-DR+ mononuclear cells in autologous and allogeneic MLR. (1981) (40)
Genes and environment in arthritis: can RA be prevented? (2002) (39)
Integration of Known DNA, RNA and Protein Biomarkers Provides Prediction of Anti-TNF Response in Rheumatoid Arthritis: Results from the COMBINE Study (2016) (39)
Do steroids increase lymphoma risk? A case–control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis (2005) (39)
Postmenopausal hormone therapy and the risk of rheumatoid arthritis: results from the Swedish EIRA population-based case-control study (2015) (39)
Expression of HLA-D-locus (DP, DQ, DR)-coded antigens, beta 2-microglobulin, and the interleukin 2 receptor in Sjögren's syndrome. (1987) (39)
Oil-induced arthritis in DA rats: tissue distribution of arthritogenic 14C-labelled hexadecane. (1995) (38)
Immunopathogenesis and immunotherapy in rheumatoid arthritis: an area in transition (1995) (38)
Features of renal vasculitis in autoimmune MRL lpr/lpr mice: phenotypes and functional properties of infiltrating cells. (1988) (38)
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000) (2000) (38)
Variable domain N‐linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B‐cell selection (2018) (38)
Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. (2004) (38)
Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens (2015) (38)
Altered Th1/Th2 balance associated with non‐major histocompatibility complex genes in collagen‐induced arthritis in resistant and non‐resistant rat strains (1997) (37)
Autoimmunity: Lungs and citrullination (2015) (37)
Corticosteroids--from an idea to clinical use. (2004) (37)
Memory T cells specific to citrullinated α-enolase are enriched in the rheumatic joint. (2018) (37)
Associations Between Attention-Deficit/Hyperactivity Disorder and Various Eating Disorders: A Swedish Nationwide Population Study Using Multiple Genetically Informative Approaches (2019) (37)
Importance of PDGF receptor expression in accelerated atherosclerosis-chronic rejection. (1989) (36)
Occupation and Risk of Developing Rheumatoid Arthritis: Results From a Population‐Based Case–Control Study (2018) (36)
IFN-γ production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1*0401 and HLA-DQ8 (1999) (36)
A Novel HLA–DRB1*10:01–Restricted T Cell Epitope From Citrullinated Type II Collagen Relevant to Rheumatoid Arthritis (2015) (35)
Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden (2014) (35)
Recent infections are associated with decreased risk of rheumatoid arthritis: a population-based case-control study (2015) (35)
Parasite‐mediated down‐regulation of collagen‐induced arthritis (CIA) in DA rats (2000) (35)
Dynamic expression of transforming growth factor‐betas (TGF‐β) and their type I and type II receptors in the synovial tissue of arthritic rats (1997) (35)
Non-participation in EIRA: a population-based case–control study of rheumatoid arthritis (2010) (35)
Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions. (2000) (35)
Using ancestry-informative markers to identify fine structure across 15 populations of European origin (2014) (34)
To What Extent Is the Familial Risk of Rheumatoid Arthritis Explained by Established Rheumatoid Arthritis Risk Factors? (2015) (34)
Heavy HLA-DR (Ia) antigen chain is controlled by the MHC region (1978) (34)
In vivo treatment of rats with monoclonal antibodies against gamma interferon: effects on experimental allergic neuritis (1989) (34)
Analysis of Neuropeptide S Receptor Gene (NPSR1) Polymorphism in Rheumatoid Arthritis (2010) (33)
Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics (2005) (33)
Different Hierarchies of Anti–Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis (2020) (33)
IgG Antibodies to Cyclic Citrullinated Peptides Exhibit Profiles Specific in Terms of IgG Subclasses, Fc-Glycans and a Fab-Peptide Sequence (2014) (33)
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial (2014) (32)
Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis? (2005) (32)
Isolation and characterization of detergent-solubilized human HLA-DR transplantation antigens. (1979) (32)
Rheumatoid arthritis patients display B-cell dysregulation already in the naïve repertoire consistent with defects in B-cell tolerance (2019) (32)
Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study (2010) (32)
Immunization with Alum–Collagen II Complex Suppresses the Development of Collagen‐Induced Arthritis in Rats by Deviating the Immune Response (1997) (31)
Infliximab dosage and infusion frequency in clinical practice: experiences in the Stockholm biologics registry STURE (2007) (31)
Genetic Variants in Toll-Like Receptors Are Not Associated with Rheumatoid Arthritis Susceptibility or Anti-Tumour Necrosis Factor Treatment Outcome (2010) (31)
A two‐year follow‐up of work capacity in early rheumatoid arthritis: a study of multidisciplinary team care with emphasis on vocational support (2006) (31)
Transmission of infectious agents by inadequately sterilized ENT instruments. (1989) (31)
Linomide, a new immunomodulatory drug, shows different effects on homologous versus heterologous collagen-induced arthritis in rats. (1989) (30)
An Immunochip-based interaction study of contrasting interaction effects with smoking in ACPA-positive versus ACPA-negative rheumatoid arthritis. (2016) (29)
Proposal to establish a register for the long term surveillance of adverse events in patients with rheumatic diseases exposed to biological agents: the EULAR Surveillance Register for Biological Compounds (2000) (29)
Dietary Intake of Polyunsaturated Fatty Acids and Pain in Spite of Inflammatory Control Among Methotrexate‐Treated Early Rheumatoid Arthritis Patients (2018) (29)
Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor (2005) (29)
Murine Synovial Intima Contains I‐A‐, I‐E/C‐Positive Bone‐Marrow‐Derived Cells (1982) (29)
Common commercial cosmetic products induce arthritis in the DA rat. (1998) (28)
Anti-Ia-reactive cells in mycosis fungoides: a study of skin biopsies, single epidermal cells and circulating T lymphocytes. (1981) (28)
T‐Lymphocyte Subsets and HLA‐DR‐Expressing Cells in Rejected Human Kidney Grafts (1983) (28)
Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study (2019) (28)
Pulling down the plug on atherosclerosis: Cooling down the inflammasome (2011) (28)
Identification of the Tyrosine-Protein Phosphatase Non-Receptor Type 2 as a Rheumatoid Arthritis Susceptibility Locus in Europeans (2013) (28)
IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis (2017) (28)
Silica exposure is associated with an increased risk of developing ACPA-positive rheumatoid arthritis in an Asian population: evidence from the Malaysian MyEIRA case–control study (2014) (27)
Estimated prediagnosis radiological progression: an important tool for studying the effects of early disease modifying antirheumatic drug treatment in rheumatoid arthritis (2004) (27)
Variants Within STAT Genes Reveal Association with Anticitrullinated Protein Antibody-negative Rheumatoid Arthritis in 2 European Populations (2012) (27)
Autoimmunity to Collagen II and Myelin Basic Protein: Comparative Studies in Humans and Rodents (1990) (27)
A Monoclonal Antibody to the Mycobacterial 65kDa Heat Shock Protein (ML 30) Binds to Cells in Normal and Arthritic Joints of Rats (1991) (27)
Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work? (2017) (27)
Complex Relationships of Smoking, HLA–DRB1 Genes, and Serologic Profiles in Patients With Early Rheumatoid Arthritis: Update From a Swedish Population‐Based Case–Control Study (2019) (27)
Binding of HLA antigen-containing liposomes to bacteria. (1978) (26)
Clinical responses to tumor necrosis factor alpha antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor alpha followup registry. (2003) (26)
Celiac disease in relation to immunologic serum markers, trace elements, and HLA-DR and DQ antigens in Swedish children with Down syndrome. (1999) (26)
A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups. (1999) (26)
The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence (2014) (26)
Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis (2014) (26)
Impaired parathyroid hormone release in human immunodeficiency virus infection. (1994) (26)
Antitissue Transglutaminase and Antithyroid Autoantibodies in Children with Down Syndrome and Celiac Disease (2005) (25)
Statins in rheumatoid arthritis—two birds with one stone? (2004) (25)
On the organization of an early arthritis clinic. (2001) (25)
Psychosocial Stress at Work and the Risk of Developing Rheumatoid Arthritis: Results from the Swedish EIRA Study (2009) (25)
Modulation of experimental allergic neuritis in rats by in vivo treatment with monoclonal anti T cell antibodies (1988) (25)
Smokeless Tobacco (Moist Snuff) Use and the Risk of Developing Rheumatoid Arthritis: Results From a Case–Control Study (2014) (25)
Phenotypic characterization of cells within subcutaneous rheumatoid nodules. (1983) (25)
SAT0065 Acpa against different citrullinated peptides identify specific phenotypes of rheumatoid arthritis (2017) (25)
Toward Earlier Diagnosis Using Combined eHealth Tools in Rheumatology: The Joint Pain Assessment Scoring Tool (JPAST) Project (2020) (25)
The PRL -1149 G/T polymorphism and rheumatoid arthritis susceptibility. (2009) (25)
Role of T lymphocytes in murine collagen induced arthritis (1986) (25)
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004 (2004) (24)
Expression of the human germinal‐centre‐associated lymphoma protein in diffuse large B‐cell lymphomas in patients with rheumatoid arthritis (2008) (24)
T‐Cell Receptor V‐Gene Usage in Synovial Fluid and Synovial Tissue from RA Patients (1992) (24)
Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis. (2008) (24)
Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up (2017) (24)
Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register. (2019) (24)
Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge (2013) (24)
Oligodeoxynucleotides containing CpG motifs can induce T cell-dependent arthritis in rats. (2004) (24)
Relationship between shift work and the onset of rheumatoid arthritis (2017) (23)
Silica exposure is associated with an increased risk of developing ACPA-positive rheumatoid arthritis in an Asian population: evidence from the Malaysian MyEIRA case–control study (2013) (23)
High sodium chloride consumption enhances the effects of smoking but does not interact with SGK1 polymorphisms in the development of ACPA-positive status in patients with RA (2016) (23)
Characteristics of synovial fluid effusion in collagen‐induced arthritis (CIA) in the DA rat; a comparison of histology and antibody reactivities in an experimental chronic arthritis model and rheumatoid arthritis (RA) (1997) (23)
High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis (2016) (23)
HLA‐DR expression, T lymphocyte phenotypes, OKM1 and OKT9 reactive cells in inflammatory myopathy (1985) (23)
Evaluation of arthroscopy and macroscopic scoring (2009) (23)
Generation and Characterization of Anti–Citrullinated Protein Antibody–Producing B Cell Clones From Rheumatoid Arthritis Patients (2019) (23)
Discovery of new candidate genes for rheumatoid arthritis through integration of genetic association data with expression pathway analysis (2017) (22)
Depletion of murine T cells by in vivo monoclonal antibody treatment is enhanced by adding an autologous anti-rat kappa chain antibody. (1988) (22)
The importance of differences; On environment and its interactions with genes and immunity in the causation of rheumatoid arthritis (2020) (22)
Oestrogen‐Mediated Suppression of Collagen‐Induced Arthritis in Rats (1989) (22)
Binding, pharmacological and immunological profiles of the delta-selective opioid receptor antagonist HS 378. (2001) (22)
Specific and Long‐Lasting Protection from Collagen‐Induced Arthritis and Oil‐Induced Arthritis in DA Rats by Administration of Immunogens (1995) (22)
Expression and function of a CD4-like molecule in parathyroid tissue. (1996) (22)
Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis (2010) (22)
Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype (2019) (22)
T‐Lymphocyte subsets, functional deficits, and morphology in sciatic nerves during experimental allergic neuritis (1987) (22)
Susceptibility to oil-induced arthritis in the DA rat is determined by MHC and non-MHC genes. (1995) (22)
GEIRA: gene-environment and gene–gene interaction research application (2011) (21)
Tissue Distribution of Class II Transplantation Antigens: Presence on Normal Cells (1986) (21)
Short‐Term Kinetics of the Humoral Anti‐Clq Response in SLE Using the ELISPOT Method: Fast Decline in Production in Response to Steroids (1994) (20)
Is rheumatoid arthritis an autoimmune disease? (2016) (20)
MHC CLASS I AND II ANTIGEN EXPRESSION ON PARATHYROID CELLS AND PROSPECTS FOR THEIR ALLOGENIC TRANSPLANTATION (1993) (20)
Genetic variation in the serotonin receptor gene affects immune responses in rheumatoid arthritis (2012) (20)
Respiratory Diseases as Risk Factors for Seropositive and Seronegative Rheumatoid Arthritis and in Relation to Smoking (2020) (20)
Connection between autoimmunity to cartilage type II collagen and rheumatoid factor production. (1987) (20)
Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study (2018) (20)
Feasibility of 1 hour infliximab infusions (2005) (20)
Autoantibodies to epithelial cells in patients on long‐term therapy with leucocyte‐derived interferon‐alpha (IFN‐α) (1990) (20)
Correction: A Candidate Gene Approach Identifies the TRAF1/C5 Region as a Risk Factor for Rheumatoid Arthritis (2007) (19)
What can we learn about rheumatoid arthritis from animal models? (2004) (19)
Obesity‐Related Traits and the Development of Rheumatoid Arthritis: Evidence From Genetic Data (2020) (19)
Production of Antibodies to Gliadin by Peripheral Blood Lymphocytes in Children with Celiac Disease: The Use of an Enzyme-Linked Immunospot Technique for Screening and Follow-Up (1997) (19)
Nature of the type II collagen autoimmunity in mice susceptible to collagen-induced arthritis. (1988) (19)
Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population (2019) (18)
The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Antibodies against uncitrullinated peptides seem to occur prior to the antibodies to the corresponding citrullinated peptides (2014) (18)
Systematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis (2018) (18)
Cellular reactivity to collagen type II in rheumatoid arthritis is associated with HLA DRB1*0401 and DQ8 (2000) (18)
Loci associated with N-glycosylation of human IgG are not associated with rheumatoid arthritis: a Mendelian randomisation study (2015) (17)
The inflammatory reflex and risk for rheumatoid arthritis: a case–control study of human vagotomy (2006) (17)
Tissue distribution of macrophages, class II transplantation antigens, and receptors for platelet-derived growth factor in normal and rejected human kidneys. (1987) (17)
Persistence of measles virus in rat brain neurons is promoted by depletion of CD8+ T cells (1989) (17)
Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome. (2000) (17)
Patterns of autoreactivity to collagen type II in autoimmune MRL/l mice. (1986) (17)
Variants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritis (2011) (17)
Effects of gold on cytokine production in vitro; increase of monocyte dependent interleukin 10 production and decrease of interferon-gamma levels. (2002) (17)
Genome-wide single-nucleotide polymorphism studies in rheumatology: hype or hope? (2008) (17)
On the mode of incorporation of human transplantation antigens into lipid vesicles. (1980) (17)
Different populations of rheumatoid adherent cells mediate activation versus suppression of T lymphocyte proliferation. (1985) (16)
Smoking, HLA-genes and serology in rheumatoid arthritis; complex relationships investigated in the Swedish EIRA case-control study. (2019) (16)
Predicting and preventing the development of rheumatoid arthritis. (2016) (16)
Isolation and Properties of Detergent‐Solubilized HLA Antigens Obtained from Platelets (1979) (16)
An in vivo cross-linkable hyaluronan gel with inherent anti-inflammatory properties reduces OA cartilage destruction in female mice subjected to cruciate ligament transection. (2017) (16)
Amount of smoking, duration of smoking cessation and their interaction with silica exposure in the risk of rheumatoid arthritis among males: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study (2017) (16)
Accelerating Translational Research by Clinically Driven Development of an Informatics Platform–A Case Study (2014) (15)
IgA measurements in over 12 000 Swedish twins reveal sex differential heritability and regulatory locus near CD30L. (2014) (15)
Gene-gene interaction and RNA splicing profiles of MAP2K4 gene in rheumatoid arthritis. (2015) (15)
Expression of an interferon-gamma-like substance in normal and transplanted rat heart tissue. (1992) (15)
Significance of the expression of HLA-DR antigen on epidermal Langerhans cells. (1978) (15)
Comparative susceptibility of DA, LEW, and LEW.1AV1 rats to arthritis induced with different arthritogens: mineral oil, mycobacteria, muramyl dipeptide, avridine and rat collagen type II. (1997) (15)
Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice (2021) (15)
Differential expression of transcripts for the autoimmunity-related human dendritic cell immunoreceptor (2008) (15)
Seropositivity combined with smoking is associated with increased prevalence of periodontitis in patients with rheumatoid arthritis (2017) (15)
Cell surface characteristics of human histiocytic lymphoma cell lines. II. Expression of Helix pomatia A hemagglutinin binding surface glycoproteins, HLA-DR and common acute lymphocytic leukemia (cALL) antigen. (1981) (15)
Characterization of T-cell receptor alpha beta repertoire in synovial tissue from different temporal phases of rheumatoid arthritis. (1992) (15)
On the origins of complex immune-mediated disease: the example of rheumatoid arthritis (2009) (14)
A1.28 Anti-carp antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors and smoking (2014) (14)
Interplay between alcohol, smoking and HLA genes in RA aetiology (2019) (14)
Major histocompatibility complex class II expression and parathyroid autoantibodies in primary hyperparathyroidism. (1998) (14)
Who cares about team care? Conference report from CARE II. Spenshult, Sweden, 18–20 September 2003 (2005) (14)
Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study (2019) (14)
Anti–Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis (2020) (13)
Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities (2020) (13)
Clinical and radiological disease-course in a Swedish DMARD-treated early RA-inception cohort: an observational study (2004) (13)
Physical workload is associated with increased risk of rheumatoid arthritis: results from a Swedish population-based case–control study (2017) (13)
VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis (2017) (13)
A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis (2021) (13)
HIV receptors (CD4 antigen) in normal human glomerular cells. (1989) (12)
Identification of shared citrullinated immunological targets in the lungs and joints of patients with rheumatoid arthritis (2012) (12)
Phenotypic and cytogenetic characteristics of a new epstein‐barr virus negative cell line (SKW 4) derived from A B‐Cell lymphoma (2007) (12)
Impact of parental history on patients’ cardiovascular mortality in rheumatoid arthritis (2005) (12)
Translating genomic medicine to the clinic: challenges and opportunities (2019) (12)
Anti‐Ia‐reactive Cells in the Urinary Tract of Man, Guinea‐Pig, Rat and Mouse (1982) (12)
Longitudinal study of interleukin-10, tumor necrosis factor-alpha, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease. (2001) (12)
Induced expression of class II transplantation antigens in the cartilage-pannus junction in RA: chronic synovitis as a model system for aberrant T-lymphocyte activation. (1988) (12)
The treatment of rheumatoid arthritis: getting better all the time? (2005) (12)
Down-regulation of collagen arthritis after in vivo treatment with a syngeneic monoclonal anti-idiotypic antibody to a cross-reactive idiotope on collagen II auto-antibodies. (1991) (12)
Cyclic variation of major histocompatibility complex class II antigen expression in the human fallopian tube epithelium. (1992) (12)
Interactions of mammalian cells with collagen. (1984) (12)
Working in cold environment and risk of developing rheumatoid arthritis: results from the Swedish EIRA case–control study (2017) (12)
Immunoregulation in arthritis. A review on synovial immune reactions in RA and in some experimental animal models for arthritis. (1987) (12)
A monoclonal antiidiotypic antibody with rheumatoid factor activity defines a cross-reactive idiotope on murine anticollagen antibodies. (1991) (12)
Smoking is associated with an increased risk of developing ACPA-positive but not ACPA-negative rheumatoid arthritis in Asian populations: evidence from the Malaysian MyEIRA case–control study (2012) (11)
Technological readiness and implementation of genomic‐driven precision medicine for complex diseases (2021) (11)
Tissue Distribution of T‐Lymphocytes and Ia‐Expressing Cells in Rat Kidney Grafts (1985) (11)
Macrophages and T lymphocytes expressing HLA-D region-encoded gene products in rejected renal transplants. (1988) (11)
Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis (2021) (11)
Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA (2015) (11)
The additive role of innate and adaptive immunity in the development of arthritis. (2004) (11)
Rheumatoid factors in mice. (1989) (10)
Binding of Collagen Type II to Rheumatoid Synovial Cells (1986) (10)
Regional differences regarding risk of developing rheumatoid arthritis in Stockholm County, Sweden: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study (2013) (10)
The Influence of Polygenic Risk Scores on Heritability of Anti-CCP Level in RA (2014) (10)
In vivo treatment with anti‐CD8 and anti‐CD5 monoclonal antibodies alters induced tolerance to adjuvant arthritis (1989) (10)
Sulphasalazine inhibits human antigen-specific immune responses in vivo (2006) (10)
Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3–dependent sensitization (2021) (10)
Structural studies of beta2-microglobulin-associated and other MHC antigens. (1977) (10)
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision (2021) (10)
Retraction: Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition (2019) (10)
Trans-ancestry genome-wide association study identifies novel genetic mechanisms in rheumatoid arthritis (2021) (10)
CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis (2004) (10)
Effects of GSTM1 in Rheumatoid Arthritis; Results from the Swedish EIRA study (2011) (10)
Neutralization of anticitrullinated protein antibodies in rheumatoid arthritis - a way to go? (2014) (10)
Implementation of the CDC translational informatics platform - from genetic variants to the national Swedish Rheumatology Quality Register (2013) (10)
Rheumatoid arthritis (2009) (9)
Differential tissue distribution of HLA-DR, -DP and -DQ antigens. (1987) (9)
A specific association exists between type 1 diabetes and anti-CCP positive rheumatoid arthritis (2011) (9)
Cumulative Association of Twenty-Two Genetic Variants with Seropositive Rheumatoid Arthritis Risk (2010) (9)
In vivo monoclonal antibody treatment with Ox19 (anti-rat CD5) causes disease relapse and terminates P2-induced immunospecific tolerance in experimental allergic neuritis (1989) (9)
Differences in the Spectrum of Anti–Citrullinated Protein Antibody Fine Specificities Between Malaysian and Swedish Patients With Rheumatoid Arthritis: Implications for Disease Pathogenesis (2016) (9)
Enumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides. (1991) (9)
HLA‐DR expression, T lymphocyte phenotypes, OKM1 and OKT9 reactive cells in inflammatory myopathy (1984) (9)
Role of hyaluronan in chronic and acutely rejecting kidneys. (1993) (9)
Regulation by T cells of delayed hypersensitivity reaction in mouse lung as reflected by mononuclear cells, mast cells and mucus-producing cells. (1988) (9)
Comparison between the sensitivity of the hemolytic plaque-forming cell assay and the enzyme-linked immunospot assay in detecting B cells producing trinitrophenyl- or sheep erythrocyte-specific IgM and IgG antibodies. (1991) (9)
Down-regulation of a spontaneous arthritis in male DBA/1 mice after administration of monoclonal anti-idiotypic antibodies to a cross-reactive idiotope on anti-collagen antibodies. (1992) (8)
Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis: correlation with skin reactions. (2003) (8)
Haplotype-Specific Expression Analysis of MHC Class II Genes in Healthy Individuals and Rheumatoid Arthritis Patients (2021) (8)
A Shared Epitope of Collagen Type XI and Type II Is Recognized by Pathogenic Antibodies in Mice and Humans with Arthritis (2018) (8)
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis (2022) (8)
Inhibition of autologous mixed lymphocyte reaction by aggregated IgG molecules (1982) (8)
Rheumatoid arthritis autoantibodies and their association with age and sex. (2021) (8)
Serial re-challenge with influenza vaccine as a tool to study individual immune responses. (2008) (8)
Effects of Monoclonal Anti‐T Cell Antibodies on Rat Cardiac Allografts (1987) (8)
HLA-DRB 1 * 04 / * 13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus (2013) (8)
Fine-mapping identifies causal variants for RA and T1D in DNASE1L3, SIRPG, MEG3, TNFAIP3 and CD28/CTLA4 loci (2017) (8)
Induction of Thy-1 antigen on murine keratinocytes. (1986) (8)
Morphology of Rat Cardiac Allografts with Permanent Survival Induced by Antithymocyte Globulin (1988) (7)
Is tea consumption associated with reduction of risk of rheumatoid arthritis? A Swedish case-control study (2021) (7)
Clinical and biochemical effects in vivo of monoclonal antitumor antibody in verner‐morrison's syndrome (1994) (7)
Parity influences the severity of ACPA-negative early rheumatoid arthritis: a cohort study based on the Swedish EIRA material (2015) (7)
Distribution of interleukin-2 receptor bearing lymphocytes in the skin. A comparative study of allergic and irritant contact dermatitis, tuberculin reaction and cutaneous T cell lymphoma. (1986) (7)
Antigen presentation in joints in the pathogenesis of arthritis. (1991) (7)
From No Increase to Doubled Risk after Ten Years: Morbidity and Mortality from Myocardial Infarction in Newly Diagnosed Rheumatoid Arthritis (2008) (7)
The shared susceptibility epitope of HLA-DR4 binds citrullinated self-antigens and the TCR (2021) (7)
Association Between Life Events and Rheumatoid Arthritis: Results From a Population‐Based Case–Control Study (2014) (7)
Monoclonal antiparathyroid antibodies revealing defect expression of a calcium receptor mechanism in hyperparathyroidism (1988) (7)
Usage of skin care products and risk of rheumatoid arthritis: results from the Swedish EIRA study (2012) (7)
Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus (2011) (7)
Peripheral blood T lymphocyte subsets in active rheumatoid arthritis--effects of different therapies on previously untreated patients. (1986) (6)
Immune reactions in the rheumatoid synovial tissue (1988) (6)
Etanercept and methotrexate in rheumatoid arthritis (2004) (6)
Monoclonal antiparathyroid antibodies--tools for studies of the regulation of cytoplasmic calcium and function of parathyroid and other antibody-reactive cells. (1990) (6)
SUSTAINED HALTING OF JOINT DAMAGE WITH COMBINATION ETANERCEPT AND METHOTREXATE: 3-YEAR RESULTS FROM THE TEMPO TRIAL: 142 (2006) (6)
The genetics of rheumatoid arthritis: new insights and implications. (2015) (6)
Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis (2021) (6)
Spectrum of Anti Citrullinated Peptide Antibodies (ACPA) fine specificities is different between Malaysian and Swedish rheumatoid arthritis patients: Implications for pathogenesis of RA (2016) (6)
Using genotype data to distinguish pleiotropy from heterogeneity: deciphering coheritability in autoimmune and neuropsychiatric diseases (2015) (6)
Towards prevention of autoimmune diseases: The example of rheumatoid arthritis (2021) (6)
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset (2022) (6)
Expression of HLA-DR and HLA-DQ antigens on cells within the cartilage-pannus junction in rheumatoid arthritis (2004) (6)
Age at menarche, age at natural menopause, and risk of rheumatoid arthritis — a Mendelian randomization study (2020) (6)
CD25brightCD4+ regulatory T cells accumulate in inflamed joints of patients with chronic rheumatic disease (2004) (5)
Suppressive effects of a quinoxaline‐analogue (Rob 803) on pathogenic immune mechanisms in collagen‐induced arthritis (2008) (5)
The spectrum of association in HLA region with rheumatoid arthritis in a diverse Asian population: evidence from the MyEIRA case-control study (2021) (5)
Summary of report of the 3rd Workshop of European Biologics Registries (2005) (5)
Selective Costimulation Modulators: Addressing Unmet Needs in Rheumatoid Arthritis Management (2005) (5)
Positive effects of anti-T-cell monoclonal antibodies on rat allograft survival. (1987) (5)
Synovial class II antigen expression and immune complex formation in rheumatoid arthritis. (2009) (5)
Mannan Binding Lectin (MBL) genotypes coding for high MBL serum levels are associated with rheumatoid factor negative rheumatoid arthritis in never smokers (2011) (5)
Measles Virus Infection Causes Expression of Class I and Class II MHC Antigens in Rat Brain (1988) (5)
Interplay between obesity and smoking with regard to RA risk (2019) (5)
Density separation of chronic lymphocytic leukemia cells: low-density non-T cells are efficient stimulator cells in allogeneic and autologous mixed leukocyte reaction. (1983) (5)
Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype (2019) (5)
THU0080 DEVELOPMENT OF ULTRASOUND DETECTABLE ARTHRITIS AMONG ACPA POSITIVE SUBJECTS WITH MUSCULOSKELETAL SYMPTOMS: THE RISK RA PROSPECTIVE STUDY (2019) (5)
Elimination of CD8+ T Cells in Vivo Does Not Break Induced Immunospecific Tolerance to Experimental Allergic Neuritis in Rats (1988) (5)
Lung changes detected by high resolution tomography are present in ACPA positive RA patients already at disease onset (2012) (5)
Widespread non-joint pain in early rheumatoid arthritis (2021) (4)
Antiinflammatory therapy for rheumatoid arthritis? (2008) (4)
In vitro and ex vivo functional characterization of human HLA-DRB1∗04 restricted T cell receptors (2021) (4)
OP0171 Characterization of Lung Inflammation and Identification of Shared Citrullinated Targets in the Lungs and Joints of Early RA (2014) (4)
VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis (2017) (4)
Regulation of the delayed hypersensitivity reaction in the lung reflected as mononuclear, mast cell and mucus cell appearance after T helper cell depletion and adoptive transfer. (1987) (4)
Effects on murine T helper cell proliferation by DTH activated syngeneic epidermal cells. (1986) (4)
THU0434 The Association between Postmenopausal Hormone Therapy and the Risk of Rheumatoid Arthritis: Results from the Swedish EIRA Study (2014) (4)
Effect of infliximab on gene expression profiles in synovial tissue of RA patients. (2006) (4)
The Functional Polymorphism 844 A>G in FcαRI (CD89) Does Not Contribute to Systemic Sclerosis or Rheumatoid Arthritis Susceptibility (2011) (4)
A2.33 Citrullinated self antigen-specific blood B cells carry cross-reactive immunoglobulins with effector potential (2016) (4)
[New perspectives on rheumatoid arthritis]. (1997) (4)
FRI0046 Anti-Carbamylated Protein Antibodies Precede the Onset of Symptoms of Rheumatoid Arthritis in A Swedish Biobank Cohort (2014) (4)
Risk of cardiovascular morbidity and mortality following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA (2005) (4)
Role of adjuvants in turning autoimmunity into autoimmune disease. (1995) (4)
LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma (2011) (3)
Safety and efficacy of adalimumab in arthritis patients previously treated with another biologic agent (2004) (3)
Antibody feedback regulation in MRL/lpr mice. (1993) (3)
Immunohistochemical reactivity of monoclonal antibodies generated after immunization of mice with cells from a psoriatic lesion. (1989) (3)
Local versus systemic immunoreactivity to collagen and the collage-like region of C1q in rheumatoid arthritis and SLE. (1995) (3)
Assessment of inflammation and damage by MRI in established RA patients with Methotrexate inadequate response receiving Golimumab: Results of the GO-FORWARD trial (2011) (3)
Interactions between the immune system and connective tissue in arthritis. Possible significance of an affinity between IgG and native type II collagen. (1988) (3)
Airborne Occupational Exposures and Risk of Developing Rheumatoid Arthritis: A Job‐Exposure Matrix Approach in a Swedish Population‐Based Case–Control Study (2017) (3)
How to communicate in science (2019) (3)
Combination of Two Monoclonal Anti–Citrullinated Protein Antibodies Induced Tenosynovitis, Pain, and Bone Loss in Mice in a Peptidyl Arginine Deiminase‐4–Dependent Manner (2022) (3)
Cytokines in Human Rheumatoid Arthritis and Murine Models (2002) (3)
Reply to letter by Yazici and Yazici commenting on the two-year report on the trial of etanercept and methotrexate with radiographic and patient outcomes. (2007) (3)
Citrullinated proteins in arthritis: presence in joints and effects on immunogenicity (2004) (3)
Toward Earlier Diagnosis Using Combined eHealth Tools in Rheumatology: The Joint Pain Assessment Scoring Tool (JPAST) Project (Preprint) (2019) (3)
Risk of tuberculosis in rheumatoid arthritis and following anti-TNF treatment. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA (2005) (3)
Identifying tissues implicated in Anorexia Nervosa using Transcriptomic Imputation (2018) (3)
A10.14 Identification of Novel ACPA Targets in Rheumatoid Arthritis Synovial Tissues Using 2D Gel Electrophoresis and Mass Spectrometry (2013) (3)
Common Genetic Variation and Age of Onset of Anorexia Nervosa (2021) (3)
Antibodies to a Citrullinated Porphyromonas gingivalis Epitope Are Increased in Early Rheumatoid Arthritis, and Can Be Produced by Gingival Tissue B Cells: Implications for a Bacterial Origin in RA Etiology (2022) (3)
The Anti‐Leu4 (CD3) Monoclonal Antibody Reacts with Proximal Tubular Cells of the Human Kidney (1989) (3)
Occupational inhalable agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking (2022) (3)
The T cell receptor repertoire and antigen specificities in small joints of early rheumatoid arthritis - diversity and clonality. (2022) (3)
TNF-antagonist treatment and risk of hospitalisation for cardiovascular disease. Results from the National Swedish Monitoring-Program for Biologies in Ra (ARTIS). (2006) (3)
Rheumatic?—A Digital Diagnostic Decision Support Tool for Individuals Suspecting Rheumatic Diseases: A Multicenter Pilot Validation Study (2022) (3)
Understanding and Prevention of the Evolution Toward Autoimmune Rheumatoid Arthritis: The New Challenge. (2019) (3)
A2.24 Plasma cell derived monoclonal anti-citrulline antibodies from ra synovial fluid are multireactive (2016) (3)
Reply to “Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis” (2010) (3)
Sleep problems in rheumatoid arthritis over 12 years from diagnosis: results from the Swedish EIRA study (2022) (3)
Allergic conditions and risk of rheumatoid arthritis: a Swedish case–control study (2022) (2)
TNF-antagonist treatment and risk of hospitalisation for infection. Results from the National Swedish Monitoring-Program for Biologics in RA (ARTIS). (2006) (2)
Infliximab in the treatment of rheumatoid arthritis (2006) (2)
0297 Occupational exposure to organic dust and risk of developing rheumatoid arthritis (2017) (2)
Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis (2018) (2)
Risk for lymphomas following TNF-blockade. Comparisons with a nationwide co-morbidity database (2004) (2)
Expression and function of a CD3-like molecule on normal and abnormal human parathyroid cells. (1995) (2)
OP0087 Use of Moist Snuff and the Risk of Developing Rheumatoid Arthritis; Results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis Study (2013) (2)
The Association of Ambient Air Pollution Exposures and Risk of Rheumatoid Arthritis: Results From the Swedish EIRA Case-Control Study and the US Nurses' Health Prospective Cohort Study. (2011) (2)
AB0486 New, provisional american college of rheumatology and european league against rheumatism remission criteria: Results from 2 randomized, controlled golimumab trials in patients with rheumatoid arthritis (2013) (2)
Eular workshop on Rheumatology Research (1982) (2)
Cartilage-saving effects of local HMGB1-neutralizing therapy in experimental osteoarthritis (2017) (2)
Characterization of lung inflammation and identification of shared citrullinated targets in the lungs and joints of early rheumatoid arthritis (2014) (2)
AB0029 CITRULLINE REACTIVE B CELLS ARE PRESENT IN THE LUNGS OF EARLY UNTREATED RA (2019) (2)
A1.1 Characterisation of lung inflammation and identification of shared citrullinated targets in the lungs and joints of early rheumatoid arthritis (2014) (2)
A multiplex microarray for the detection of rheumatoid arthritis-associated autoantibodies (2011) (2)
OP0149 The Association Between Parity and Rheumatoid Arthritis: Results from the Swedish Eira Study (2013) (2)
Effects of Purified Protein Derivative (PPD)‐Activated Syngeneic Epidermal Cells on a PPD‐Specific Rat T‐Helper Cell Line (1989) (2)
α-enolase specific T cells in rheumatoid arthritis – a MHC class II tetramer approach (2012) (2)
[New drugs against rheumatoid arthritis. Improved treatment options place new demands on health care organization]. (2000) (2)
Susceptibility of rats to homologous collagen-induced arthritis depends on MHC genes in the class II region. (1999) (2)
OP0085 Multiplex analysis of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis (2013) (2)
POS1169 IMPACT OF THE COVID-19 PANDEMIC ON MORBIDITY AND MORTALITY AMONG SWEDISH PATIENTS WITH INFLAMMATORY JOINT DISEASES VERSUS THE GENERAL POPULATION (2021) (2)
Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development (2022) (2)
Effects of anti-rheumatic treatments on expression of microsomal prostaglandin E synthase-1 in rheumatoid arthritis synovium (2004) (2)
S100A12-expression is upregulated by TNF and may serve as a marker for the success of anti-TNF therapy (2005) (1)
CITRULLINATED alpha-ENOLASE: A MAJOR AUTOANTIGEN LINKING SMOKING AND HLA-DRB1 SHARED EPITOPE TO RHEUMATOID ARTHRITIS (2009) (1)
Increase inactivated T cells andreduction in suppressorinducer T cells insystemic sclerosis (1990) (1)
Monoclonal anti t cell antibodies for in vivo treatment of rats with experimental allergic neuritis ean (1986) (1)
[Antibodies against citrullinated proteins--a breakthrough in rheumatologic diagnostics]. (2004) (1)
Experimental Sjögren's syndrome: a review. (1986) (1)
AB1285 IGA RF IS ASSOCIATED WITH HIGH AGE OF RHEUMATOID ARTHRITIS ONSET (2019) (1)
Complexity of a complex disease; understanding genes, environment and immunity in rheumatoid arthritis development (2007) (1)
FRI0524 HUMAN MONOCLONAL ACPAS INDUCE MOBILITY OF PRIMED SYNOVIAL FIBROBLAST IN A PAD-DEPENDENT PATHWAY (2019) (1)
Fine mapping in over 14,000 rheumatoid arthritis cases and 18,500 controls refines associations to known loci, indicates multiple independent affects and reveals novel associations (2012) (1)
Single Nucleotide Polymorphisms within the HLA-DRB1 Gene in Relation to Antibodies Against Citrullinated Peptides in Individuals Prior to the Development of Rheumatoid Arthritis (2012) (1)
A national database for co-morbidity in RA to evaluate drug safety. Solid cancers in RA and following anti-TNF treatment (2004) (1)
THU0077 Anti-collagen type ii antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation (2017) (1)
Rheumatoid Factor Isotypes in Relation to Antibodies Against Citrullinated Peptides in Individuals before Onset of Rheumatoid Arthritis (2014) (1)
Antibodies against native collagen and citrullinated proteins precede the development of rheumatoid arthritis with a consecutive pattern (2012) (1)
Vaccination of patients with primary Sjögren's syndrome reveals hyperreactive B cell compartment with a skewed maturation pattern (2011) (1)
Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium (2004) (1)
Lundberg et al. reply (2010) (1)
Effects on experimental allergic neuritis in rats by in vivo treatment with monoclonal anti-T-cell antibodies (1987) (1)
Predicting and Assessing an Inflammatory Disease and Its Complications: Example from Rheumatoid Arthritis (2020) (1)
OP0019 Anti-citrullinated protein antibodies directly induce bone loss in rheumatoid arthritis (2013) (1)
O18-6 Occupational exposure to textile dust increases the risk of RA: results from a malaysian population-based case-control study (2016) (1)
OP0052 A Dense Mapping of HLA Region for Study of Interaction with Smoking in the Development of Rheumatoid Arthritis (2013) (1)
Monoclonal antibodies raised against mid-gut carcinoid tumor cells (1990) (1)
FRI0368 To Which Extent May the Familial Risk of Rheumatoid Arthritis BE Explained by Established Risk Factors? (2014) (1)
Concurrent Oral 3 – Genetics and Epidemiology [OP16–OP23] OP16. Genetic Variation in the Dream Pain Modulation Pathway is Associated with the Extent of Musculoskeletal Pain (2010) (1)
Running head: Explaining the familial risk of RA Title: To which extent may the familial risk of Rheumatoid Arthritis be explained by established RA risk factors? (2014) (1)
SAT0550 Remaining Pain in Early RA Patients Treated with Methotrexate – Results from the Eira Cohort and the Swedish Rheumatology Quality Register (2013) (1)
Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defi ned by the anticitrullinated protein / peptide antibody fi ne specifi city profi (2012) (1)
THU0417 Occupation and Risk of Developing Rheumatoid Arthritis (2014) (1)
Unmet Needs in Rheumatoid Arthritis: A Subgroup of Patients With High Levels of Pain, Fatigue, and Psychosocial Distress 3 Years After Diagnosis (2022) (1)
Intra-articular steroid treatment reduces synovial HMGB1 but not IL-1 expression in chronic arthritis (2004) (1)
Interactions between the immune system and connective tissue in arthritis: aspects on T-cell activation. (1988) (1)
AB1368-HPR ENHANCED ROLE OF NURSES AND OTHER HEALTHCARE PROFESSIONALS (HCPS) IN THE CARE OF RHEUMATOID ARTHRITIS AND ASSOCIATED COMORBIDITIES (2019) (1)
A1.34 ACPA fine specificity is associated with increased plasmablast numbers and worse clinical response to rituximab in rheumatoid arthritis (2013) (1)
Affinity purification and characterisation of human ACPAs (2012) (1)
FRI0068 Remaining Pain Despite Inflammation Control in Rheumatoid Arthritis – Long-Term Strongly Increased Risk for Widespread Pain and Fatigue (2015) (1)
Not Better but Quite Good Effects on Work Loss of Combination Treatment for Rheumatoid Arthritis With and Without Biological Agents (2017) (1)
A9.10 Neutralisation of ACPA – A Way to Go? (2013) (1)
The Possibility of a Specific Calcium Sensor/Receptor Function of Proximal Renal Tubular Cells (1989) (1)
08.19 Variable domain n-linked glycosylation is a key feature of monoclonal acpa-igg (2017) (1)
Smoking interacts with HLA-DRB1 shared epitope in the development of ACPA-positive rheumatoid arthritis: a case-control study from Malaysian epidemiological investigation of rheumatoid arthritis (MyEIRA) (2012) (1)
Social stressors and risk of rheumatoid arthritis and their relationship to known modifiable risk factors: results from the Swedish EIRA study (2021) (1)
FRI0227 Acpa fine specificity is associated with increased plasmablast numbers and worse clinical response to rituximab in rheumatoid arthritis (2013) (1)
OP0195 High Sodium Intake among Smokers is A Risk Factor for ACPA Positivity in RA (2014) (1)
Atherosclerosis in Rheumatic Diseases (2012) (1)
Proteomic Signatures of Secreted Proteins for the Prediction of Treatment Response to TNF Blockers in RA (2007) (1)
The specificity of monoclonal anti citrulline protein antibodies ‐ reply to Dr Holmdahl's letter (2018) (1)
A8.27 Intraarticular drug delivery of anti-HMGB1 in hyaluronan gels for osteoarthritis treatment (2015) (1)
OR.103. Combined Analysis of Three Genome-wide Scans Reveals Additional Loci Associated with Rheumatoid Arthritis (2008) (1)
Disruptive innovation in rheumatology: new networks of global public–private partnerships are needed to take advantage of scientific progress (2020) (1)
Lung changes are present in ACPA positive RA patients already at disease onset (2011) (1)
Third Eular Workshop on Rheumatology Research (1983) (1)
Non-contraceptive hormones and rheumatoid arthritis: possibilities of using a Swedish population-based cohort. (1989) (1)
AB0253 The Relation between Pain and Inflammation in Early Rheumatoid Arthritis – Long-Term Follow up in the Swedish Population-Based EIRA and SRQ Register (2014) (1)
Identification of specific citrullination sites on fibrinogen in RA (2010) (1)
Antibodies against cyclic citrullinated peptide (CCP) and shared epitope predict rheumatoid arthritis. (2003) (1)
Prospective Studies on the Risk of Rheumatoid Arthritis: The European Risk RA Registry (2022) (1)
HLA-DRB1*04 is a novel fetal susceptibility allele in congenital heart block (2011) (1)
On the structure, function and tissue distribution of HLA-DR and Ia antigens (1978) (1)
Anca Catrina 1971-2021. (2021) (1)
Clinical databases and biobanks for etiologic and therapeutic studies in rheumatoid arthritis (2006) (1)
Reply (2019) (1)
OP0241 Repetitive Prolonged Physical Workload Is Associated with Increased Risk of Developing Rheumatoid Arthritis: Results from The Swedish Eira-Study (2016) (1)
Occupational physical workload and development of anti-collagen type II antibodies in rheumatoid arthritis: results from the Swedish EIRA population-based case-control study. (2020) (1)
OP0176 Clusters of Single Nucleotide Polymorphisms Within the HLA-DRB1 Gene in Relation to Antibodies Against Citrullinated Peptides in Individuals Prior to the Development of Rheumatoid Arthritis (2013) (1)
[Blockade of TNFalpha--new therapeutic principle in severe rheumatoid arthritis]. (2001) (1)
as p38 MAP kinases and NF (cid:6) B in the modulation of the anticoagulant effects of statins. OP44. PHASED DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION IN SYSTEMIC VASCULITIS (2006) (1)
A5.14 Homocitrulline-Reactive Antibodies can be Generated from Synovial B-Cells from ACPA-Negative RA Patients (2013) (1)
Morphologic and immunohistochemical changes in antithymocyte globulin-induced permanently surviving rat cardiac allografts. (1988) (1)
Studies Including Therapeutics (ESCISIT) Standing Committee for International Clinical early arthritis: report of a task force of the European EULAR recommendations for the management of (2007) (1)
F.36. Increased Baff Levels After Rituximab-Induced B-Cell Depletion in Sle Patients (2006) (1)
Cardiovascular Risk Factors Are Increased in People Reporting Chronic Pain Symptoms (2010) (1)
AB0118 Oral contraceptives and the risk of developing rheumatoid arthritis: results from the malaysian epidemiological investigation of rheumatoid arthritis case-control study (2018) (0)
Erratum: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis (2016) (0)
OP0236 THE EFFECT OF UV-B RADIATION EXPOSURE ON THE RISK OF DEVELOPING RHEUMATOID ARTHRITIS (2021) (0)
Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defi ned by the anticitrullinated protein / peptide antibody fi ne specifi city profi le (2012) (0)
Modifiable and other risk factors for rheumatoid arthritis: A basis for prevention and better therapy (2020) (0)
FRI0008 ADDRESSING THE DIAGNOSTIC GAP IN RHEUMATOID ARTHRITIS BY COMPLEMENTING THE SEROLOGY WITH GENETIC INFORMATION (2019) (0)
FRI0082 SLEEP PROBLEMS IN EARLY RHEUMATOID ARTHRITIS (2020) (0)
Contents, Vol. 82, 1987 (1987) (0)
THU0270 Decreased Risk for Severe Persisting Pain in Elderly Patients with Early Rheumatoid Arthritis – Results from the Swedish Population-Based EIRA and SRQ Register (2014) (0)
AB0021 Identification of novel acpa targets in rheumatoid arthritis synovial tissues using 2d gel electrophoresis and mass spectrometry. (2013) (0)
Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes (2018) (0)
Parathyroid autoantibodies and MHC class II antigen expression in hyperparathyroidism (1992) (0)
Citrullinated Proteins in Arthritis; their Presence in Joints and Effects on Immunogenicity (2004) (0)
Why is this prize important in the field of RA (2013) (0)
The PenTanucleoTide inserTion in hsPa1B Gene is associaTed wiTh idioPaThic inflammaTory myoPaThy (2013) (0)
POS0355 ASSOCIATIONS BETWEEN HLA-DRB1 SHARED EPITOPES ALLELES AND ANTI-RA33 ANTIBODIES IN DIFFERENT SUBSETS OF RHEUMATOID ARTHRITIS IN MALAYSIAN POPULATION (2021) (0)
Anti-Citrullinated Protein Antibody Reactivity towards Neutrophil-Derived Antigens: Clonal Diversity and Inter-Individual Variation (2023) (0)
FRI0005 DIVERSITY OF ANTI-CITRULLINATED PROTEIN ANTIBODY COMPOSITIONS INFLUENCE SYNOVIAL FIBROBLAST REACTIVITY (2020) (0)
FRI0027 Parity and Severity of Acpa-Positive and Acpa-Negative Rheumatoid Arthritis. Results from the Swedish EIRA Study and the Swedish Rheumatology Quality Register (2014) (0)
MC 1288 - A vitamin D analogue with immunosuppressive effects which suppresses collagen-induced arthritis in rats (1997) (0)
Diversity and Clonality of T Cell Receptor Repertoire and Antigen Specificities in Small Joints of Early Rheumatoid Arthritis (2023) (0)
Anti-citrullinated protein antibody specificities and pulmonary fibrosis in relation to genetic loci in early rheumatoid arthritis (2022) (0)
Gender differences and the effect of sex hormones on collagen type ii induced arthritis in rats (1988) (0)
OP0234 Rheumatoid Arthritis Subsets Defined by Sub-Specificities of Anti-Citrullinated Antibodies (ACPAS) Have Unique HLA Associations (2016) (0)
The human bone marrow plasma cell compartment in rheumatoid arthritis - Clonal relationships and anti-citrulline autoantibody producing cells. (2023) (0)
SAT0046 ARE SENSE OF SOCIAL SUPPORT AND LOW DECISION LATITUDE AT WORK LINKED TO RISK OF RHEUMATOID ARTHRITIS, AND IF SO, HOW DO THEY RELATE TO OTHER RISK FACTORS? RESULTS FROM THE SWEDISH EIRA STUDY (2019) (0)
THU0105 Familial Risks of RA in Relation to Type of Affected Relatives, Age, Sex, and RF/ACPA (2013) (0)
A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling (2017) (0)
Reply to the letter to the editor: Body fat composition and risk of rheumatoid arthritis. (2021) (0)
SAT0721-HPR Exposure to passive smoking and ra risk; results from the swedish eira study (2017) (0)
OP0096 EXPOSURE TO DENGUE INFECTION DO NOT RAISE RISK OF RHEUMATOID ARTHRITIS: FINDINGS FROM THE MALAYSIAN EPIDEMIOLOGICAL INVESTIGATION OF RHEUMATOID ARTHRITIS (MYEIRA) CASE-CONTROL STUDY (2021) (0)
THU0638 CONSIDERATIONS FOR IMPROVING QUALITY OF CARE IN RHEUMATOID ARTHRITIS AND ASSOCIATED COMORBIDITIES (2019) (0)
Predicting and Assessing an Inflammatory Disease and Its Complications (2020) (0)
Inverse regulation of single cell production of IL-6 and IL-10 in peripheral blood and synovial fluid of arthritis patients (1997) (0)
Patterns of gene expression in RA synovial tissue; Inter patient variability greater then intra patient variability in a small study (2005) (0)
Acknowledgements (1989) (0)
[The Nobel Prize for discovery of the cell-mediated immune defense. Significance for clinical medicine]. (1996) (0)
[The proposal of the National Board of Health and Welfare counteracts knowledge development within health care]. (2003) (0)
Intraarticular drug delivery of ANTI-HMGB1 in hyaluronan gels for cartilage repair (2016) (0)
SAT0675B ANTI-MODIFIED PROTEIN AUTOANTIBODIES IN RA DISPLAY IMPORTANT PEPTIDE CROSS-REACTIVITY BUT YET PROTEIN RECOGNITION SELECTIVITY (2019) (0)
May 09, 2020 Integration of Known DNA, RNA and Protein Biomarkers Provides Prediction of Anti-TNF Response in Rheumatoid Arthritis results from (2016) (0)
AB0323 Patients with Higher Education Present Greater Improvements on Functional Status in Early Rheumatoid Arthritis (2015) (0)
Response to: ‘Obesity and comorbidity are independently associated with a failure to achieve remission in patients with established rheumatoid arthritis’ by Ellerby et al (2014) (0)
Passive smoking in childhood accelerates RA risk for smokers (2021) (0)
Expression levels of HLA-DRB and HLA-DQ are associated with MHC Class II haplotypes in healthy individuals and rheumatoid arthritis patients (2021) (0)
Measles virus induces mhc antigens in rat brains and persists after depletion of CD8+ T-cells (1988) (0)
Implementation of the CDC translational informatics platform - from genetic variants to the national Swedish Rheumatology Quality Register (2013) (0)
Identification of genetic loci associated with antibodies to specific sets of citrullinated peptides in rheumatoid arthritis patients (2021) (0)
Heterogeneity in cytokine profile after intra-articular steroid treatment (2002) (0)
OP0108 Aggressive lymphomas (diffuse large b cell lymphomas) are overrepresented in ra patients (2001) (0)
OP0307 No Long-Term Effect on Disease Activity and Pain of Physical Activity Found in Prospective Observational Study of Early Rheumatoid Arthritis (2016) (0)
Occupational Physical Workload and Development of Anti-Collagen Type II Antibodies in Rheumatoid Arthritis Patients (2017) (0)
Mechanisms Involved in Immunomodulatory Treatment of Rheumatoid Arthritis (1992) (0)
VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis (2017) (0)
POS0009 THE RELATIONSHIP BETWEEN DIFFERENT IGG AND IGA ANTI-MODIFIED PROTEIN AUTOANTIBODIES IN RHEUMATOID ARTHRITIS (2021) (0)
[Rheumatologic research with animal experiments is important for our patients]. (2012) (0)
Neither low social support nor low decision latitude at work is associated with disease remission among patients with rheumatoid arthritis: results from the Swedish EIRA study (2022) (0)
[Future treatment of rheumatism. A compromise in the game between inflammation and infections]. (2000) (0)
Using human genetics to understand the epidemiological association between obesity, serum urate and gout. (2023) (0)
SAT0037 The effects of b cell directed therapy on disease relevant biomarkers in subjects at risk of rheumatoid arthritis (2017) (0)
THU0114 Effects of smoking on baricitinib efficacy in patients with rheumatoid arthritis: pooled analysis from two phase 3 clinical trials (2017) (0)
SAT0692 Predictors and persistence of unacceptable pain during the first year of rheumatoid arthritis in sweden (2017) (0)
Percutaneous exposure ofadjuvant oilcausesarthritis inDA rats (1994) (0)
Author Correction: The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting (2022) (0)
OP0171 Screening for Anti-CCP in a Large Population Based Cohort and its Association with Prevalent Rheumatoid Arthritis (2013) (0)
SP0125 Co-morbidity in rheumatic diseases (2013) (0)
[Rheumatologists' current tasks]. (1994) (0)
Etanercept and methotrexate in rheumatoid arthritis. Authors' replies (2004) (0)
Advances in early inflammatory arthritis IP85. Genetic and Environmental Risk Factors in Early Rheumatoid Arthritis (2011) (0)
Response to Comment “Sex-specific exposures and sex-combined outcomes in two-sample Mendelian randomization may mislead the causal inference” on “Age at menarche, age at natural menopause, and risk of rheumatoid arthritis—a Mendelian randomization study” (2022) (0)
Non-HLA-DRB1 RA-associated risk alleles associate with anti-CCP and specific ACPA levels (2011) (0)
O-184 Occupational inhaled agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking (2023) (0)
OP0142 Masking CD94/NKG2A using a novel therapeutic MAB results in significant suppression of IL-6 levels and reduced osteoclast formation in rheumatoid arthritis ex vivo cultures (2013) (0)
A10.13 IGG FC galactosylation changes and predicts response to methotrexate in early rheumatoid arthritis (2016) (0)
Expression of CD4 on parathyroid cells and intact serum parathyroid hormone levels in HIV-1 seropositive patients (1992) (0)
Work and rehabilitation PARE0016 IMPACT OF AXIAL SPONDYLOARTHRITIS ON PATIENTS’ PROFESSIONAL LIFE: RESULTS FROM THE ONLINE SURVEY EMAS OF 638 FRENCH PATIENTS (2021) (0)
SAT0016 RHEUMATOID ARTHRITIS PATIENTS DISPLAY B-CELL DYSREGULATION ALREADY IN THE NAïVE REPERTOIRE (2019) (0)
A family-based association study of the IL10 and Bcl2 genes in swedish patients with SLE (1999) (0)
Gene expression analysis of synovial tissue biopsies obtained from rheumatoid arthritis patients prior to infliximab treatment (2008) (0)
Erratum: A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling (2017) (0)
References (1989) (0)
Investigation of the association between coffee and risk of RA—results from the Swedish EIRA study (2022) (0)
7 : Targeting rheumatoid arthritis prevention strategies to high-risk populations based on family history , genetic and environmental factors Presenting (2013) (0)
OP0326 ACPA-INDUCED PAIN-BEHAVIOR, BONE LOSS AND TENDON INFLAMMATION IN MICE: A NOVEL MODEL FOR THE PRE-DISEASE PHASES OF ACPA-POSITIVE RHEUMATOID ARTHRITIS (2020) (0)
OP-BRHE150262 1..3 (2015) (0)
active rheumatoid arthritis based on the TEMPO trial combination with methotrexate in the treatment of Cost effectiveness of etanercept (Enbrel) in (2007) (0)
OP0064 Genetic markers for the efficacy of tnf blocking therapy of rheumatoid arthritis (2001) (0)
Disease activity and health-related quality of life among patients with rheumatoid arthritis with different alcohol consumption habits. (2023) (0)
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages (2023) (0)
Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium (2005) (0)
THU0605 Omega-3 Fatty Acids Associates with Decreased Pain, Independent of Inflammation, in MTX Treated Early RA Patients (2016) (0)
POS0392 PRESENCE OF FOUR SERUM AUTOANTIBODIES ASSOCIATES WITH THE ACPA STATUS IN EARLY RHEUMATOID ARTHRITIS (2021) (0)
THU0066 IN EARLY RHEUMATOID ARTHRITIS ANTI-CITRULLINATED PEPTIDE ANTIBODIES ASSOCIATE WITH LOWER NUMBER OF AFFECTED JOINTS, AND IGM RHEUMATOID FACTOR WITH SYSTEMIC INFLAMMATION IN AN ANTI-CITRULLINE DEPENDENT MANNER (2019) (0)
FRI0003 ACPA response against fibrinogen epitopes citrullinated in vivo in the synovial membrane in RA patients detected with an autoantibody microarray (2013) (0)
Author Correction: The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting (2022) (0)
SAT0085 Do Specific Acpas or Other Autoantibodies Measured by A Novel Assay Predict Response To Methotrexate Monotherapy in Patients with Early Dmard-Naïve Ra? (2016) (0)
NpgRJ_Ng_2007-27 1..6 (2007) (0)
Etiology and molecular pathogenesis of RA; how can we best use European initiatives to advance our knowledge? (2012) (0)
Sodium Chloride Consumption, Together with Smoking, Is Associated with ACPA Positivity (2015) (0)
W12-P-018 Lipid-peroxidation is enhanced in SLE patients and associated with arterial and renal disease manifestations (2005) (0)
P021 Differential ACPA binding to nuclear antigens reveals a distinct subset of acetylation cross-reactive autoantibodies in rheumatoid arthritis (2019) (0)
Correction (2010) (0)
Anti-parathyroid antibody preparation. (1987) (0)
Autoantibodies in rheumatoid arthritis: anti-citrullinated proteins antibodies and type II collagen Specificities (2008) (0)
Influence of smoking on disease activity and quality of life in patients with rheumatoid arthritis: results from a Swedish case-control study with longitudinal follow-up. (2022) (0)
Molecular signature of methotrexate response among rheumatoid arthritis patients (2023) (0)
Therapy with soluble TNF receptor (etanercept) induces apoptosis in rheumatoid arthritis (RA) synovium (2003) (0)
sclerosis . suppressor inducer T cells in systemic Increase in activated T cells and reduction in (0)
OP0124 The Protective Effect of HLA-DRB1*13 Alleles During Specific Phases in the Development of ACPA-Positive RA (2015) (0)
Reply (2018) (0)
Translating genomic medicine to the clinic: challenges and opportunities (2019) (0)
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis. (2022) (0)
The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA) (2023) (0)
Reply (2021) (0)
The Swedish biologics register (ARTIS): observations of adverse events when using biologics in clinical practice (2008) (0)
Sexual Differences in Cancer Survival: Hormones or Stage at Diagnosis?-Reply (1990) (0)
THU0013 Biological and immunological profiles of the delta-selective opioid receptor antagonist hs 378 (2001) (0)
SAT0694 Subgrouping of early ra-patients identified cluster of patients with high levels of pain, fatigue and psychosocial distress 3 years after diagnosis (2017) (0)
FRI0071 ANTI-CITRULLINATED PROTEIN ANTIBODY SPECIFICITIES, RHEUMATOID FACTOR ISOTYPES AND RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (2019) (0)
UvA-DARE ( Digital Academic Repository ) The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis (2010) (0)
OP0084 Patterns of circulating antibodies in the pre-clinical phase of rheumatoid arthritis suggest epitope spreading in the immune reaction against citrullinated peptides (2013) (0)
[Current medicine requires cooperation--not omnipotence]. (2000) (0)
ACPA response against fibrinogen epitopes citrullinated in vivo in the synovial membrane in RA patients detected with an autoantibody microarray (2012) (0)
POS0457 CHANGES OF RF ISOTYPE PROFILE IN PATIENTS WITH RHEUsMATOID ARTHRITIS: DATA FROM 10 YEARS FOLLOW-UP STUDY (2021) (0)
Structural pulmonary abnormalities on HRCT are early features of ACPA- positive rheumatoid arthritis (2013) (0)
SAT0033 Characterization of the Multi-Biomarker Disease Activity (Vectra Da™ Algorithm) Score in a Subgroup of Patients from the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) Cohort Receiving Methotrexate (2013) (0)
Role and Regulation of Synovial MHC Class II Antigens in Rheumatoid Arthritis and Related Diseases (1992) (0)
GLYCOSYLATION IN MAMMALS PROTECTS CITRULLINATED CHEMOKINES FROM PARTIAL DEGRADATION INVESTIGATING MECHANISMS OF AUTOANTIBODY INDUCED PAIN, BONE LOSS AND ARTHRITIS DEVELOPMENT (2022) (0)
Studies on Collagen II Induced Arthritis in Mice and Rats (1986) (0)
Risk of malignant lymohomas in patient with rheumatoid arthritis and their first-degree relatives. (2003) (0)
A drug-related perspective on RA pathogenesis. (1999) (0)
The presence of anti-carbamylated protein antibodies prior to onset of symptoms of rheumatoid arthritis (RA) is associated with radiological progression in early RA (2014) (0)
A8.2 Anti Citrullinated Protein Antibodies from Synovial Fluid of Rheumatoid Arthritis Patients Enhance Osteoclastogenesis (2013) (0)
SY6-1-4 Genes, environment and immunity in rheumatoid arthritis (2010) (0)
Identification of novel genetic risk loci determine fetal outcome in congenital heart block (2012) (0)
A1.4 Early Signs of Subclinical Inflammation and Local Antibody Production in Early Rheumatoid Lungs (2013) (0)
Oral abstracts 7: Molecular mechanisms of disease—osteoarthritisS1. Identification of novel osteoarthritis genes using zebrafish (2012) (0)
Measles virus infection causes expression of class I and class II antigens in rat brain (1987) (0)
Gamma-interferon-like substance is expressed in myocytes of cardiac allografted rats treated with cyclosporine A. (1992) (0)
Anti-collagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype in an Asian cohort consisting of three different ethinicities. (2017) (0)
FRI0101 Lung changes are present in ACPA positive RA already at disease onset (2013) (0)
FRI0127 Atherosclerosis and arterial disease in systemic lupus erythematosus (2001) (0)
SAT0740-HPR Parity and the risk of developing rheumatoid arthritis: evidence from the malaysian epidemiological investigation of rheumatoid arthritis case-control study (2018) (0)
Evolutionary Relationship Between Immunoglobulins and Transplantation Antigens ( H-2 alloantigens / HLA alloantigens / disulfide bridges / tetrameric structure ) (0)
Sequencing of the MHC region defines HLA-DQA1 as the major independent risk for anti-citrullinated protein antibodies (ACPA)-positive rheumatoid arthritis in Han population (2018) (0)
Reply: To PMID 24574210. (2014) (0)
Faculty Opinions recommendation of Tumor necrosis factor causes persistent sensitization of joint nociceptors to mechanical stimuli in rats. (2010) (0)
CHAPTER 3B – Environmental Risk Factors for Rheumatoid Arthritis (2008) (0)
Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al. (2008) (0)
Biphasic decline/increase for anticitrulline and monophasic decline in anti-type II collagen antibody levels in recently diagnosed RA patients (2003) (0)
Rheumatoid arthritis (RA) patients with low levels of anticollagen type II (CII) had a higher cellul (2011) (0)
[Rheumatoid arthritis in theory and practice. What do we expect from immunology?]. (1989) (0)
THU0030 Neutralization of ACPA in Rheumatoid Arthritis - A Novel Principle of Treatment (2013) (0)
Neutralization Of Anti-Citrullinated Protein Antibodies - a Way To Go? (2013) (0)
Evidence for immunostimulatory effects of intramuscular gold in patients with : correlation with skin reactions. (2003) (0)
AB0080 Association between life events and rheumatoid arthritis, results from the eira case control study (2013) (0)
Parity and severity of ACPA-positive/-negative rheumatoid arthritis. Results from the Swedish EIRA study (2014) (0)
A7.23 The HLA Locus Contains Novel Foetal Susceptibility Alleles for Congenital Heart Block with Significant Paternal Influence (2013) (0)
Rheumatoid arthritis (RA) patients with disease-associated human leucocyte antigen (HLA) genotypes h (2011) (0)
Immunological aspects of etiopathogenesis of rheumatoid arthritis. (1988) (0)
Humoral immune response against fibrinogen epitopes citrullinated in vivo in rheumatoid arthritis synovial tissue detected by autoantibody multiplexing (2011) (0)
Prediagnosis radiological progression in rheumatoid arthritis: a novel tool to study the effects of early DMARD therapy (2004) (0)
Differential gene expression and protein expression levels of MMP and TIMP molecules in response to glucocorticoid treatment in arthritic patients (2004) (0)
The MHC and the Recognition of Self and Altered Self in Experimental and Rheumatoid Arthritis (2014) (0)
How is clinical progress achieved? (2004) (0)
Experimental allergic neuritis: Dynamics of Ia‐expressing cells, T lymphocytes of different subsets in peripheral nerve tissue and serum IgG response (1984) (0)
Biological Insights From Genetics Of Rheumatoid Arthritis Contribute To Drug Discovery (2013) (0)
A longitudinal comparison of the Scleroderma Functional Score with the HAQ disability index (2006) (0)
08.24 Monoclonal acpa antibodies recognising a common citrulline motif are mainly dependent on light chain hypermutations for antigen recognition (2017) (0)
Faculty Opinions recommendation of Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. (2009) (0)
[Nobel Prize for discovery of the cell-mediated immune defence]. (1996) (0)
A2.22 Influence of TNF on the proteome of rheumatoid arthritis synovial fibroblasts (2015) (0)
THU0124 Occupational exposure to asbestos and risk of rheumatoid arthritis (2017) (0)
SAT0054 INVESTIGATING MECHANISMS OF AUTOANTIBODY INDUCED PAIN, BONE LOSS AND ARTHRITIS DEVELOPMENT (2019) (0)
SAT0043 Identification and Characterization of Novel Molecular Mechanisms for ACPA-Driven Osteoclastogenesis (2015) (0)
AB0125 Anti-dengue igg antibody positivity and risk of developing rheumatoid arthritis: evidence from the malaysian epidemiological investigation of rheumatoid arthritis (MYEIRA) case-control study (2018) (0)
AB0043 Affinity purification and characterization of human acpas (2013) (0)
[The Langerhans cells of the skin--the advanced outpost of our immune defense]. (1981) (0)
After compensating for the antigen hyporesponsiveness, rheumatoid arthritis (RA) peripheral blood mo (2011) (0)
THU0078 Interactions of Antibodies Against Citrullinated Peptides with HLA Shared Epitope, PTPN22 1858T Variant, and Smoking in Individuals Prior to and after the Development of Rheumatoid Arthritis (2013) (0)
P035 Occupational physical workload and development of anti-collagen type II antibodies in rheumatoid arthritis: results from the swedish EIRA population-based case-control study (2019) (0)
FRI0519 IDENTIFICATION OF CELLULAR TARGETS FOR ANTI-CITRULLINATED PROTEIN ANTIBODIES (ACPAS) (2019) (0)
Increased apoptosis level in late stages of rheumatoid arthritis correlates with macrophage number (2001) (0)
Effects on Experimental Allergic Neuritis in Rats by in Vivo Treatment with Monoclonal Anti‐T‐Cell Antibodies (1988) (0)
Faculty Opinions recommendation of Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. (2008) (0)
Human problems - animal models: Aspects on the use of inducible experimental arthritis for pathogenetic studies of human inflammatory joint disease (1995) (0)
SAT0739-HPR Occupational exposure to pesticides increases the risk of rheumatoid arthritis: results from the malaysian population-based case-control study (2018) (0)
A Dense Mapping Of Human Leukocyte Antigen Region For Study Of Interaction With Smoking In The Development Of Rheumatoid Arthritis (2013) (0)
OP0208 High density fine mapping in rheumatoid arthritis indentifies 14 new loci (2013) (0)
Ischemic vascular disease and antiphospholipid antibodies are associated with HLA-DRB1 *04/*13 alleles in systemic lupus erythematosus (2012) (0)
Genetics of autoimmunity (SY6-1) Chairpersons: Takehiko Sasazuki, Judy H. Cho (2010) (0)
Interaction of Antibodies Against Citrullinated Peptides with HLA Shared Epitope, PTPN22 1858T Variant, and Smoking in Individuals Prior to and After the Development of Rheumatoid Arthritis. (2012) (0)
Restricted T‐Cell Receptor Usage in DA Rats during Early Collagen‐Induced Arthritis (1995) (0)
Generation and characterisation of monoclonal antibodies from single RA synovial B cells (2012) (0)
The association between the HLA-DRB1 shared epitope alleles and the risk of rheumatoid arthritis is influenced by massive gene-gene interactions (2017) (0)
Chapter 6 External Validation of the Clinical Pharmacogenetic Model for predicting MTX monotherapy efficacy using a Swedish Cohort of patients with recent-onset rheumatoid arthritis (2009) (0)
Early Menopause, Smoking and Circulating Antibodies Against Citrullinated Peptides in the Pre-Clinical Phase of Rheumatoid Arthritis (2012) (0)
Association Between Physical Work Load and Rheumatoid Arthritis, Results From The EIRA Case Control Study (2013) (0)
Interactions Between the Immune System and Connective Tissue in Arthritis: Aspects on Connective Tissue Proliferation and Breakdown (1989) (0)
Treatment of rheumatoid arthritis (1949) (0)
Diffuse large B-cell lymphomas in rheumatoid arthritis display a predominance of non-germinal center type (2005) (0)
disease-modifying antirheumatic drugs rheumatoid arthritis not treated with other efficacy of etanercept (Enbrel) in patients with A long-term, open-label trial of the safety and (2007) (0)
SAT0346 Risk Characterisation Methodology Enabling Safety Comparisons Between Tofacitinib and Tumour Necrosis Factor Inhibitors (2015) (0)
SAT0722-HPR Familial risks of rheumatoid arthritis: evidence from the malaysian epidemiological investigation of rheumatoid arthritis case-control study (2017) (0)
Effects of anti-rheumatic treatments on the prostaglandin E2 biosynthetic pathway in synovial tissue and synovial fluid cells from patients with rheumatoid arthritis (2005) (0)
Circulating Class II Transplantation Antigen‐Expressing T Lymphocytes in Children with Insulin‐Dependent Diabetes Mellitus at Diagnosis (1988) (0)
Patterns of gene expression in rheumatoid arthritis synovial tissue: inter-patient variability greater then intra-patient variability in a small study (2005) (0)
Biopsy-verified response of severe lupus nephritis to rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to NIH-protocol cyclophosphamide (2002) (0)
SAT0335 Breastfeeding is Associated with a Decreased Risk of Acpa-Positive Rheumatoid Arthritis: Results from the Swedish EIRA Study (2015) (0)
Polymorphisms in the Interferon Regulatory Factor 5 Gene are Associated with Anti-cyclic Citrullinated Peptide Antibody Negative Rheumatoid Arthritis (2012) (0)
Faculty Opinions recommendation of Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. (2010) (0)
Analysis of ACPA positivity and ACPA fine specificities in a large Swedish twin cohort (TwinGene) (2012) (0)
OP0147 RHEUMATIC? - A DIGITAL DIAGNOSTIC DECISION SUPPORT TOOL FOR INDIVIDUALS SUSPECTING RHEUMATIC DISEASES: A MULTICENTER VALIDATION STUDY (2021) (0)
IDENTIFICATION OF NOVEL OSTEOARTHRITIS GENES USING ZEBRAFISH (2012) (0)
GAD: ASSOCIATION WITH AUTOIMMUNE DISEASE AND POTENTIAL THERAPEUTIC VALUE TO TREATMENT OF SUCH DISORDERS (2005) (0)
OP0307 PULMONARY FIBROSIS IN EARLY RHEUMATOID ARTHRITIS IN RELATION TO GENETIC LOCI AND INDIVIDUAL ACPA SPECIFICITIES (2022) (0)
A4.17 Anti-citrullinated proteins antibodies promotes osteoclastogenesis and bone destruction in rheumatoid arthritis (2015) (0)
Identification and function of T cells reactive with citrullinated vimentin in HLA-DRB1*0401 humanised mice and rheumatoid arthritis patients (2010) (0)
[Assigning the vacancies by lot. A concrete proposal]. (1970) (0)
POS0484 THE ASSOCIATION BETWEEN SOCIAL STRESSORS AND DISEASE REMISSION AMONG MEN AND WOMEN WITH EARLY RHEUMATOID ARTHRITIS (2021) (0)
FRI0073 Recent, Common Infections Are Associated with Decreased Risk of Rheumatoid Arthritis (2014) (0)
High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis (2016) (0)
CONCISE REPORT Citrullination is an inflammation-dependent process (2006) (0)
Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations (2018) (0)
Pulling the plug on atherosclerosis (2011) (0)
Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis (2018) (0)
A5.13 Antibody responses to common viruses in patients with rheumatoid arthritis (2015) (0)
Rheumatoid arthritis (RA) peripheral blood mononuclear cells (PBMCs) respond similarly to collagen t (2011) (0)
543 Relationship between shift work and the onset of rheumatoid arthritis; results from the swedish eira case-control study (2018) (0)
Faculty Opinions recommendation of The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study. (2010) (0)
Risk of hospitalisation for infections following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA (2005) (0)
Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s disease (2020) (0)
evaluate sulphasalazine effects in inflammatory arthritides (0)
FRI0341 Anti-Carp Antibodies in Two Large Cohorts of Patients with Rheumatoid Arthritis and their Relationship to Genetic Risk Factors, Cigarette Smoking and Other Autoantibodies (2014) (0)
Autoantibodies in rheumatoid arthritis: Anti-citrullinated protein antibodies (ACPA) and type II collagen specificities (B cells and autoantibodies: diagnosis and pathophysiology) (2008) (0)
AB0081 Occupation and Risk of Developing Rheumatoid Arthritis (2016) (0)
Novel Interaction between Anti-Citrulline Monoclonal Antibodies and Apoptotic Cells Is Mediated through Citrullinated Nuclear Antigens (2017) (0)
OP0267 A GENOME-WIDE INVESTIGATION OF PERSISTENCE TO TREATMENT WITH METHOTREXATE IN SWEDISH EARLY RHEUMATOID ARTHRITIS PATIENTS (2022) (0)
Mapping pQTLs of circulating inflammatory proteins identifies drivers of and novel therapeutic targets (2023) (0)
Monoclonal Anti-Citrullinated Protein Antibodies Generated from RA-Derived B Cells Recognize Amino Acid Motifs Rather Than Specific Proteins (2018) (0)
FRI0014 Generation and characterization of monoclonal antibodies from single RA synovial B cells (2013) (0)
Local anti-inflammatory combination treatment of experimental oa based on injectable gels (2018) (0)
POS0348 GENETIC SUSCEPTIBILITY VARIANTS FOR RHEUMATOID ARTHRITIS ARE NOT ASSOCIATED WITH EARLY REMISSION; A MULTI-COHORT STUDY (2021) (0)
A Study of Biomarker Analysis in Association with Type 1 Diabetes and Their Shared Features in Rheumatoid Arthritis (2014) (0)
Molecular Biomarkers of Anti-TNF Response in Patients with Rheumatoid Arthritis (2020) (0)
8th International forum for RA (IFRA) Welcome to an international meeting focused on Rheumatoid Arthritis (2017) (0)
State-of-the-Art: Rheumatoid Arthritis (2007) (0)
POS0515 THE ASSOCIATION BETWEEN AUTOANTIBODIES AND RISK FOR VENOUS THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS (2022) (0)
Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa (2019) (0)
Reply (2014) (0)
Five commercially-available antibodies react differentially with allelic forms of human HLA-DR beta chain. (2022) (0)
POS0255 PREDICTORS OF ANTIBODY RESPONSE TO COVID-19 VACCINE IN RITUXIMAB TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES. A SWEDISH NATIONWIDE STUDY (COVID19-REUMA) (2022) (0)
PARE0018 ENABLING PATIENT-CENTRED CARE IN RHEUMATOID ARTHRITIS AND ASSOCIATED COMORBIDITIES (2019) (0)
AB0054 IS TEA CONSUMPTION ASSOCIATED WITH RISK OF RHEUMATOID ARTHRITIS? (2021) (0)
In Honour of Paul Kallós (1987) (0)
MHC class II antigen expression and parathyroid autoantibodies in primary hyperparathyroidism. (1998) (0)
AB0460 Long-term remission with golimumab in active rheumatoid arthritis patients despite methotrexate through 2 years (2013) (0)

This paper list is powered by the following services:

Other Resources About Lars Klareskog

en.wikipedia.org

What Schools Are Affiliated With Lars Klareskog?

Lars Klareskog is affiliated with the following schools:

Lars Klareskog's Academic­Influence.com Rankings

Why Is Lars Klareskog Influential?

Lars Klareskog's Published Works

Published Works

Other Resources About Lars Klareskog

What Schools Are Affiliated With Lars Klareskog?

Image Attributions

Lars Klareskog's AcademicInfluence.com Rankings